Physitrack PLC - Transactions Under Share Buy-Back Programme
LONDON, GB / ACCESS Newswire / October 26, 2026 / Physitrack PLC ("Physitrack" or the "Company")(STO:PTRK) announces that, further to the share buy-back programme announced on 21 July 2026 and commenced on 10 August 2026, it has repurchased the following shares under the programme during the week of 19 to 23 October 2026.
Summary of transactions
| Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
| 19 - 23 October 2026 | 7,500 | SEK 12.2284 | SEK 91,713.00 | 68,737 | 16,260,766 | 0.4227% |
Individual transactions
| Date | Quantity | Average price (SEK) |
| 2026-10-19 | 1,500 | 11.5833 |
| 2026-10-20 | 1,500 | 12.53 |
| 2026-10-21 | 1,500 | 12.2287 |
| 2026-10-22 | 1,500 | 12.30 |
| 2026-10-23 | 1,500 | 12.50 |
Purpose and safe harbour
The transactions above were carried out under the safe harbour provided by Article 5 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052. The purpose of the buy-back programme is to meet the Company's obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| Field | Detail |
| 1. Issuer | Physitrack PLC; LEI 213800PC4QYNWHPCP774 |
| 2. Instrument / ISIN | Ordinary shares / GB00BYX22590 |
| 3. Trading venue | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency | SEK |
| 5. Purpose | To meet the Company's obligations under its employee share plans, permitted under Article 5(2) MAR |
| 6. Executing broker | Pareto Securities, non-discretionary mandate |
This disclosure is made in accordance with Article 5(3) of MAR and Commission Delegated Regulation (EU) 2016/1052.
About Physitrack
Physitrack plc (Nasdaq First North:PTRK), d/b/a Physitrack Group, is a global provider of AI-powered software for healthcare and workplace wellbeing, delivering personalized, scalable tools through its Physitrack and Champion Health platforms.
Physitrack enables healthcare providers to deliver and manage app-guided physical and occupational services with AI powered workflows with measurable patient outcomes and built-in billing and reimbursement support, while Champion Health provides businesses with mental, physical, and financial wellbeing solutions to support workforce health and productivity.
Physitrack Group's solutions seamlessly integrate with existing systems, including EMR/EHR/PMS connectivity, and are trusted by more than 110,000 providers and organizations across 170+ countries. For more information, visit www.physitrackgroup.com and follow us on LinkedIn and X.
Enquiries regarding this announcement should be addressed to:
Corporate Contact:
Henrik Molin, CEO and Founder, Physitrack
ir@physitrack.com
media@physitrack.com
+1 415 230 0414
Attachments
Physitrack PLC - Transactions under Share Buy-back Programme
SOURCE: Physitrack PLC
View the original press release on ACCESS Newswire
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
Why This Vanguard ETF Is One of the Best
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
United States